Benzinga | Nov 11, 2020 07:39AM EST

Morgan Stanley Maintains Overweight on 10x Genomics, Raises Price Target to $145

Morgan Stanley maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $135 to $145.